statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Radar: Apollo Hospitals, Bharat Dynamics, Muthoot Finance, BGR Energy, Tube Investments in focus on Friday

Sun Pharma accepted preferential offer to acquire 14.28% shares of Indian Foundation for Quality Management, while Jio Financial Services launched JioFinance App in a Beta version.

Suven-Cohance merged entity to have EBITDA margins in mid 30s: Management

In September 2023, the US-based private equity firm Advent acquired a controlling stake in Suven, expressing the intent to create a billion-dollar platform in the CDMO space.

Bulk deals: ICICI Prudential Life Insurance increases stake in Star Health and Allied Insurance

Foreign investor Apis Growth 6 sold 1.7 percent stake in Star Health and Allied Insurance

Suven Pharma, Cohance Lifesciences announce merger

The overall transaction is expected to conclude over the next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals.

Suven Pharma tanks 10% on poor Q3 show, sharp margin erosion

Suven Pharma reported a sharp decline in its net profit, revenue and profitability in Q3.

Suven Pharma Q3 results: Net profit down 57% YoY to Rs 47 crore

The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect

India a main force in Asian Healthcare deal activity: Bain Capital

According to the report, India hosted 22 in 2023 for a deal value of $4.6 billion. In 2022, the deal value was $4.7 billion.

Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.

Volume	857,917.00
52-Wk High	956.70
52-Wk Low	486.05

SUVENPHAR.NSE Suven Pharmaceuticals Ltd.

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community